Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

2.64
Delayed Data
As of Jul 31
 +0.02 / +0.76%
Today’s Change
0.33
Today|||52-Week Range
5.75
+560.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash5.9M1.0M295.5K632.3K
 
 
 
 
 
Short Term Investment Cash-7.3M-4.9M-734.6K336.7K
 
 
 
 
 
Cash & Short Term Investments5.9M1.0M295.5K632.3K
 
 
 
 
 
 
ReceivablesReceivables393.2K617.1K581.0K675.2K
 
 
 
 
 
 
InventoriesInventories23.6K42.5K39.7K88.3K
 
 
 
 
 
 
Current AssetsPrepaid Expenses--32.0K20.3K0.00
 
 
 
Other Current Assets0.0017.4K17.4K--
 
 
 
Current Assets6.3M1.7M953.9K1.4M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross568.7K548.9K550.2K552.2K
 
 
 
 
 
Depreciation-546.5K-533.8K-537.6K-542.8K
 
 
 
 
 
Other Assets17.4K0.000.000.00
 
 
Total Assets6.4M1.8M966.4K1.4M
 
 
 
 
 
 
LiabilitiesAccounts Payable640.5K880.5K1.4M1.5M
 
 
 
 
 
Accrued Expenses166.9K160.2K106.0K379.3K
 
 
 
 
 
Other Current Liabilities2.8M2.8M2.7M2.9M
 
 
 
 
 
Other Liabilities3.4M3.7M4.1M4.5M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.000.00400.0K1.3M
 
 
 
Total Liabilities11.2M8.8M7.0M5.8M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock400.0K400.0K0.000.00
 
 
 
Common Equity-5.6M-7.8M-6.5M-4.8M
 
 
 
 
 
Total Shareholder Equity-5.2M-7.4M-6.5M-4.8M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding33.0M33.6M34.7M35.9M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.